106
Views
0
CrossRef citations to date
0
Altmetric
COMMENTARY

Long COVID-19 and Peripheral Serotonin: A Commentary and Reconsideration

, ORCID Icon, , &
Pages 2169-2172 | Received 31 Jan 2024, Accepted 02 Apr 2024, Published online: 10 Apr 2024

References

  • Wong AC, Devason AS, Umana IC, et al. Serotonin reduction in post-acute sequelae of viral infection. Cell. 2023;186(22):4851–4867.e20. doi:10.1016/j.cell.2023.09.013
  • Adcock DM, Hoefner DM. Collection, transport, and processing of blood specimens for testing plasma-based coagulation and molecular hemostasis assays; approved guideline—fifth edition. CSLI document H21-A5; 2008; Wayne, PA: Clinical and Laboratory Standards Institute.
  • Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta. 2020;506:145–148. doi:10.1016/j.cca.2020.03.022
  • Rajashekar R, Krishnamurthy V, Doreswamy SM. Does platelet contamination really affect the coagulation tests? A Prospective Study. Int J Hematol Res. 2016;2(3):155–159. doi:10.17554/j.issn.2409-3548.2016.02.38
  • Beck O, Wallén NH, Bröijersén A, Larsson PT, Hjemdahl P. On the accurate determination of serotonin in human plasma. Biochem Biophys Res Commun. 1993;196(1):260–266. PMID: 8216301. doi:10.1006/bbrc.1993.2243
  • Brand T, Anderson GM. The measurement of platelet-poor plasma serotonin: a systematic review of prior reports and recommendations for improved analysis. Clin Chem. 2011;57(10):1376–1386. PMID: 21859903. doi:10.1373/clinchem.2011.163824
  • Badcock NR, Spence JG, Stern LM. Blood serotonin levels in adults, autistic and non-autistic children--with a comparison of different methodologies. Ann Clin Biochem. 1987;24(Pt 6):625–634. doi:10.1177/000456328702400613
  • Gabriel S, Sacco R, Persico AM. Blood serotonin levels in autism spectrum disorder: a systematic review and meta-analysis. Eur Neuropsychopharmacol. 2014;24(6):919–929. doi:10.1016/j.euroneuro.2014.02.004
  • McBride PA, Anderson GM, Hertzig ME, et al. Effects of diagnosis, race, and puberty on platelet serotonin levels in autism and mental retardation. J Am Acad Child Adolesc Psychiatry. 1998;37(7):767–776. PMID: 9666633. doi:10.1097/00004583-199807000-00017
  • Cheng J, Zeng H, Chen H, et al. Current knowledge of thrombocytopenia in sepsis and COVID-19. Front Immunol. 2023;14:1213510. doi:10.3389/fimmu.2023.1213510
  • Marik PE, Iglesias J, Varon J, Kory P. A scoping review of the pathophysiology of COVID-19. Int J Immunopathol Pharmacol. 2021;35:20587384211048026. PMID: 34569339; PMCID: PMC8477699. doi:10.1177/20587384211048026
  • Yazdani AN, Abdi A, Velpuri P, et al. A review of hematological complications and treatment in COVID-19. Hematol Rep. 2023;15(4):562–577. PMID: 37873794; PMCID: PMC10594461. doi:10.3390/hematolrep15040059
  • Zaid Y, Puhm F, Allaeys I, et al. Platelets can associate with SARS-Cov-2 RNA and are hyperactivated in COVID-19. Circ Res. 2020;127(11):1404–1418. PMID: 32938299; PMCID: PMC7641188. doi:10.1161/CIRCRESAHA.120.317703
  • Anderson GM, Bruno-Pacella I. Systematic review of studies using platelet serotonin content to assess bioeffect of serotonin reuptake inhibitors at the serotonin transporter. Psychopharmacology. 2023;240(1):1–13. PMID: 36399187. doi:10.1007/s00213-022-06276-5
  • McVey Neufeld KA, Bienenstock J, Bharwani A, et al. Oral selective serotonin reuptake inhibitors activate vagus nerve dependent gut-brain signaling. Sci Rep. 2019;9(1):14290. PMID: 31582799; PMCID: PMC6776512. doi:10.1038/s41598-019-50807-8
  • Deng J, Rayner D, Ramaraju HB, et al. Efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis. Clin Microbiol Infect. 2023;29(5):578–586. PMID: 36657488; PMCID: PMC9841740. doi:10.1016/j.cmi.2023.01.010
  • Nyirenda JL, Sofroniou M, Toews I, et al. Fluvoxamine for the treatment of COVID-19. Cochrane Database Syst Rev. 2022;9(9):CD015391. PMID: 36103313; PMCID: PMC9473347. doi:10.1002/14651858.CD015391